OTCMKTS:ESMC

Escalon Medical Competitors

$0.40
0.00 (0.00 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.30
Now: $0.40
$0.40
50-Day Range
$0.19
MA: $0.31
$0.48
52-Week Range
$0.08
Now: $0.40
$0.55
Volume2,900 shs
Average Volume20,246 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-0.86

Competitors

Escalon Medical (OTCMKTS:ESMC) Vs. MDT, SONVY, VAR, MASI, GNGBY, and LIVN

Should you be buying ESMC stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Escalon Medical, including Medtronic (MDT), Sonova (SONVY), Varian Medical Systems (VAR), Masimo (MASI), Getinge (GNGBY), and LivaNova (LIVN).

Escalon Medical (OTCMKTS:ESMC) and Medtronic (NYSE:MDT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability and earnings.

Volatility & Risk

Escalon Medical has a beta of -0.86, meaning that its stock price is 186% less volatile than the S&P 500. Comparatively, Medtronic has a beta of 0.7, meaning that its stock price is 30% less volatile than the S&P 500.

Valuation & Earnings

This table compares Escalon Medical and Medtronic's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A
Medtronic$28.91 billion5.87$4.79 billion$4.5927.43

Medtronic has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Escalon Medical and Medtronic's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Escalon Medical-15.54%-136.63%-26.09%
Medtronic12.69%9.71%5.30%

Insider and Institutional Ownership

79.2% of Medtronic shares are held by institutional investors. 1.9% of Escalon Medical shares are held by insiders. Comparatively, 0.5% of Medtronic shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Ratings

This is a summary of recent ratings and price targets for Escalon Medical and Medtronic, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Escalon Medical0000N/A
Medtronic031912.91

Medtronic has a consensus target price of $125.3333, suggesting a potential downside of 0.46%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Escalon Medical.

Summary

Medtronic beats Escalon Medical on 11 of the 12 factors compared between the two stocks.

Escalon Medical (OTCMKTS:ESMC) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, earnings, profitability, valuation, risk, institutional ownership and dividends.

Earnings and Valuation

This table compares Escalon Medical and Sonova's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A
Sonova$2.96 billion6.29$489.96 million$1.4938.77

Sonova has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Escalon Medical and Sonova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Escalon Medical-15.54%-136.63%-26.09%
SonovaN/AN/AN/A

Insider & Institutional Ownership

1.1% of Sonova shares are held by institutional investors. 1.9% of Escalon Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Risk & Volatility

Escalon Medical has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500. Comparatively, Sonova has a beta of 0.7, meaning that its share price is 30% less volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings and target prices for Escalon Medical and Sonova, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Escalon Medical0000N/A
Sonova06302.33

Summary

Sonova beats Escalon Medical on 9 of the 10 factors compared between the two stocks.

Escalon Medical (OTCMKTS:ESMC) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

Analyst Recommendations

This is a summary of current recommendations and price targets for Escalon Medical and Varian Medical Systems, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Escalon Medical0000N/A
Varian Medical Systems35001.63

Varian Medical Systems has a consensus price target of $159.3571, suggesting a potential downside of 10.00%. Given Varian Medical Systems' higher possible upside, analysts plainly believe Varian Medical Systems is more favorable than Escalon Medical.

Valuation and Earnings

This table compares Escalon Medical and Varian Medical Systems' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A
Varian Medical Systems$3.17 billion5.13$269.20 million$3.9145.29

Varian Medical Systems has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Escalon Medical and Varian Medical Systems' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Escalon Medical-15.54%-136.63%-26.09%
Varian Medical Systems8.50%18.45%8.08%

Risk & Volatility

Escalon Medical has a beta of -0.86, meaning that its stock price is 186% less volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.

Insider and Institutional Ownership

87.0% of Varian Medical Systems shares are owned by institutional investors. 1.9% of Escalon Medical shares are owned by insiders. Comparatively, 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Summary

Varian Medical Systems beats Escalon Medical on 9 of the 10 factors compared between the two stocks.

Masimo (NASDAQ:MASI) and Escalon Medical (OTCMKTS:ESMC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for Masimo and Escalon Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Masimo02502.71
Escalon Medical0000N/A

Masimo currently has a consensus price target of $272.20, suggesting a potential upside of 10.77%. Given Masimo's higher possible upside, analysts clearly believe Masimo is more favorable than Escalon Medical.

Earnings & Valuation

This table compares Masimo and Escalon Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Masimo$937.84 million14.48$196.22 million$3.2276.32
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A

Masimo has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Masimo and Escalon Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Masimo20.30%15.75%13.12%
Escalon Medical-15.54%-136.63%-26.09%

Volatility & Risk

Masimo has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Escalon Medical has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500.

Insider & Institutional Ownership

81.6% of Masimo shares are held by institutional investors. 11.5% of Masimo shares are held by insiders. Comparatively, 1.9% of Escalon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Masimo beats Escalon Medical on 11 of the 11 factors compared between the two stocks.

Getinge (OTCMKTS:GNGBY) and Escalon Medical (OTCMKTS:ESMC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for Getinge and Escalon Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Getinge11502.57
Escalon Medical0000N/A

Earnings & Valuation

This table compares Getinge and Escalon Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Getinge$2.81 billion2.86$129.29 millionN/AN/A
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A

Getinge has higher revenue and earnings than Escalon Medical.

Profitability

This table compares Getinge and Escalon Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Getinge10.51%17.30%7.90%
Escalon Medical-15.54%-136.63%-26.09%

Volatility & Risk

Getinge has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Escalon Medical has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500.

Insider & Institutional Ownership

0.0% of Getinge shares are held by institutional investors. 1.9% of Escalon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Getinge beats Escalon Medical on 9 of the 10 factors compared between the two stocks.

LivaNova (NASDAQ:LIVN) and Escalon Medical (OTCMKTS:ESMC) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.

Analyst Ratings

This is a breakdown of current ratings and target prices for LivaNova and Escalon Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
LivaNova04202.33
Escalon Medical0000N/A

LivaNova currently has a consensus price target of $69.3333, suggesting a potential downside of 14.76%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than Escalon Medical.

Earnings & Valuation

This table compares LivaNova and Escalon Medical's revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LivaNova$1.08 billion3.65$-155,180,000.00$3.0826.41
Escalon Medical$9.40 millionN/A$-650,000.00N/AN/A

Escalon Medical has lower revenue, but higher earnings than LivaNova.

Profitability

This table compares LivaNova and Escalon Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
LivaNova-21.88%5.55%3.07%
Escalon Medical-15.54%-136.63%-26.09%

Volatility & Risk

LivaNova has a beta of 0.8, meaning that its share price is 20% less volatile than the S&P 500. Comparatively, Escalon Medical has a beta of -0.86, meaning that its share price is 186% less volatile than the S&P 500.

Insider & Institutional Ownership

89.1% of LivaNova shares are held by institutional investors. 0.5% of LivaNova shares are held by insiders. Comparatively, 1.9% of Escalon Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

LivaNova beats Escalon Medical on 7 of the 11 factors compared between the two stocks.


Escalon Medical Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Medtronic logo
MDT
Medtronic
2.7$125.91flat$169.74 billion$28.91 billion48.06Analyst Report
Sonova logo
SONVY
Sonova
0.9$57.77flat$18.60 billion$2.96 billion38.77Increase in Short Interest
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$177.07flat$16.26 billion$3.17 billion60.43News Coverage
Masimo logo
MASI
Masimo
1.6$245.74flat$13.58 billion$937.84 million63.83
Getinge logo
GNGBY
Getinge
0.6$31.66flat$8.05 billion$2.81 billion26.16Upcoming Earnings
Analyst Upgrade
LivaNova logo
LIVN
LivaNova
1.5$81.34flat$3.96 billion$1.08 billion-18.92Analyst Report
Analyst Revision
CONMED logo
CNMD
CONMED
1.6$130.21flat$3.79 billion$955.10 million-3,255.25Analyst Revision
InMode logo
INMD
InMode
1.5$87.31flat$2.79 billion$156.36 million62.81Analyst Downgrade
Outset Medical logo
OM
Outset Medical
1.0$53.90flat$2.31 billionN/A0.00Analyst Downgrade
Insider Selling
BioLife Solutions logo
BLFS
BioLife Solutions
2.1$34.17flat$1.14 billion$27.37 million-46.81Insider Selling
Increase in Short Interest
Gap Up
NTUS
Natus Medical
1.1$28.22flat$955.92 million$495.52 million-51.31
AxoGen logo
AXGN
AxoGen
1.7$18.85flat$768.55 million$106.71 million-29.92Gap Down
TransMedics Group logo
TMDX
TransMedics Group
1.6$27.03flat$739.81 million$23.60 million-19.31Increase in Short Interest
SMLR
Semler Scientific
1.2$109.90flat$738.20 million$32.77 million77.39Insider Selling
ViewRay logo
VRAY
ViewRay
1.3$4.38flat$704.31 million$87.78 million-4.92
Stereotaxis logo
STXS
Stereotaxis
0.6$8.25flat$611.16 million$28.90 million-75.00High Trading Volume
Cutera logo
CUTR
Cutera
1.3$30.17flat$536.51 million$181.71 million-16.67News Coverage
Zynex logo
ZYXI
Zynex
1.8$15.36flat$535.37 million$45.47 million46.55News Coverage
Edap Tms logo
EDAP
Edap Tms
1.3$9.08flat$264.61 million$50.23 million-151.33Increase in Short Interest
Second Sight Medical Products logo
EYES
Second Sight Medical Products
0.8$7.36flat$171.12 million$3.38 million-3.85Decrease in Short Interest
Gap Down
BioSig Technologies logo
BSGM
BioSig Technologies
0.5$3.88flat$123.35 millionN/A0.00Gap Down
FONR
FONAR
1.1$18.32flat$120.07 million$85.69 million17.28News Coverage
IRIDEX logo
IRIX
IRIDEX
0.9$7.71flat$119.67 million$43.45 million-14.02Gap Up
Soleno Therapeutics logo
SLNO
Soleno Therapeutics
1.9$1.15flat$91.68 millionN/A-1.51Increase in Short Interest
Gap Down
ENDRA Life Sciences logo
NDRA
ENDRA Life Sciences
0.6$2.18flat$90.69 million$10,000.00-1.18Analyst Upgrade
Increase in Short Interest
Electromed logo
ELMD
Electromed
1.8$10.22flat$88.25 million$32.47 million24.33Analyst Downgrade
News Coverage
electroCore logo
ECOR
electroCore
1.4$1.79flat$86.77 million$2.39 million-2.27Decrease in Short Interest
Gap Up
Helius Medical Technologies logo
HSDT
Helius Medical Technologies
1.3$16.90flat$39.06 million$1.50 million-0.97Analyst Upgrade
Increase in Short Interest
News Coverage
Fc Global Realty logo
FCRE
Fc Global Realty
0.5$0.10flat$38.87 million$40,000.000.00Gap Up
CHF Solutions logo
CHFS
CHF Solutions
1.7$5.37flat$32.42 million$5.51 million-0.11Analyst Downgrade
Increase in Short Interest
News Coverage
Viveve Medical logo
VIVE
Viveve Medical
0.9$2.63flat$27.20 million$6.57 million-0.01News Coverage
Gap Down
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$4.20flat$25.90 million$15.09 million0.00News Coverage
PEYE
Precision Optics
0.4$1.70flat$22.55 million$9.92 million-17.00
Vaso logo
VASO
Vaso
0.9$0.09flat$16.46 million$75.75 million4.44
Star Equity logo
STRR
Star Equity
0.1$2.80flat$13.78 million$114.18 million-0.89Gap Down
Micron Solutions logo
MICR
Micron Solutions
0.3$3.30flat$10.90 million$17.50 million23.57Increase in Short Interest
GTHP
Guided Therapeutics
0.3$0.78flat$10.22 million$40,000.00-3.23Gap Up
NIMU
Non-Invasive Monitoring Systems
0.5$0.03flat$2.49 millionN/A0.00Upcoming Earnings
RSLSD
ReShape Lifesciences
0.4N/AN/A$1.94 million$610,000.000.00High Trading Volume
MAGAA
Magna-Lab
0.7$1.24flat$1.46 millionN/A6.89
Nexeon MedSystems logo
NXNN
Nexeon MedSystems
0.7$0.55flat$1.12 millionN/A0.00
ARDMQ
Aradigm
0.0$0.05flat$764,000.00N/A0.00
IMRIS logo
IMRSQ
IMRIS
0.5$0.01flat$364,000.00N/A0.00
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.02flat$234,000.00N/A0.00News Coverage
SCIE
SpectraScience
0.5$0.00flat$177,000.00N/A0.00
ULGX
Urologix
0.6$0.01flat$113,000.00N/A0.00
AKSY
Aksys
0.0$0.00flat$0.00N/A0.00
HRTT
Heart Tronics
0.0$0.02flat$0.00N/A0.00
IVVI
Ivivi Technologies
0.0$0.00flat$0.00N/A0.00High Trading Volume
NWCI
NewCardio
0.5$0.00flat$0.00N/A0.00
This page was last updated on 4/17/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.